Recurrent Hepatocellular Carcinoma in Patient with Crohn’s Disease: Incidental or Expected Outcome of Azathioprine?
Hepatocellular carcinoma (HCC) usually occurs in patients with underlying risk factors such as liver cirrhosis and chronic hepatitis B. Although patients with Crohn’s disease (CD) are at an increased risk to develop malignancies such as colon cancer, the incidence of HCC in this population is extrem...
Saved in:
| Main Authors: | Youssef Botros, Mary Mathews, Hiren Patel, Nihar Shah, Walid Baddoura, Andrew de la Torre |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Gastrointestinal Medicine |
| Online Access: | http://dx.doi.org/10.1155/2015/939136 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn’s Disease
by: Jenny Roselli, et al.
Published: (2020-01-01) -
Efficacy of azathioprine in reducing recurrence in idiopathic granulomatous mastitis
by: Kazim Senol, et al.
Published: (2025-03-01) -
Incidence, Characteristics, and Prognosis of Incidentally Discovered Hepatocellular Carcinoma after Liver Transplantation
by: Walid El Moghazy, et al.
Published: (2016-01-01) -
Comparison of endoscopic healing and durability between combination therapy with infliximab and azathioprine versus infliximab monotherapy in pediatric Crohn’s disease
by: Yoon Zi Kim, et al.
Published: (2025-07-01) -
Gigantic GIST: A Case of the Largest Gastrointestinal Stromal Tumor Found to Date
by: Abdalla Mohamed, et al.
Published: (2018-01-01)